Fresenius Medical Care increases investment in Humacyte, accompanies human acellular vessel developer’s stock market launch

August 30, 2021
2:00 pm

Fresenius Medical Care increases investment in Humacyte, accompanies human acellular vessel developer’s stock market launch

WALTHAM, Mass., Aug. 30, 2021 /PRNewswire/ — Fresenius Medical Care, the world’s leading provider of products and services for individuals with renal diseases, is investing an additional USD 25 million in the U.S. medical company Humacyte, Inc. In connection…

Click here to view the original article.

Global, Yahoo Entertainment

Share this article

Forget the 4% Rule: This Investment Strategy Helps Retirees

February 26, 2026

Circle Internet Group Jumps 35.5% on Earnings: Analysts See $130 Target Price

February 26, 2026

Gambling Commission to explore UK-licensed crypto payments — CDC Gaming

February 26, 2026

Is Southwest Airlines (LUV) Share Price Still Attractive After Strong 1 Year Rally?

February 26, 2026

CME Group (CME) Valuation Check As 24 7 Crypto Trading And Treasury Strength Support Momentum

February 26, 2026

Is Cheniere Energy (LNG) Pricing In Its Strong Multi Year Share Price Performance?

February 26, 2026

The cryptocurrency winter is not over! The crypto market resumes its downward trend, following the sentiment of tech stocks.

February 26, 2026

Bishop Street Underwriters Announces Strategic Investment by White Mountains

February 26, 2026